Chronic pancreatitis

Current Opinion in Gastroenterology

Volumn 25, Issue 5, 2009, Pages 454-459

  DiMagno, Matthew J ^a   DiMagno, Eugene P ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Alcohol; Autoimmune; Chronic pancreatitis; Genetics; Oxidative stress

Indexed keywords

ANALGESIC AGENT; ANTIOXIDANT; CHOLECYSTOKININ; CORTICOSTEROID; ELASTASE; ELASTASE I; IMMUNOGLOBULIN G4; PANCREAS ENZYME; PREDNISOLONE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLIC PANCREATITIS; AUTOIMMUNE PANCREATITIS; CHRONIC PANCREATITIS; CLINICAL OBSERVATION; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DRUG DOSE REDUCTION; ENDOSCOPY; ENZYME REPLACEMENT; FALSE POSITIVE RESULT; GENETIC SCREENING; HUMAN; INTERMETHOD COMPARISON; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALABSORPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PANCREAS CANCER; PANCREAS FUNCTION TEST; PATIENT COUNSELING; PREDICTION; PROGNOSIS; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; RELAPSE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY AND SPECIFICITY;

ADRENAL CORTEX HORMONES; ALCOHOL DRINKING; ANTIOXIDANTS; CHOLECYSTOKININ; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY; FECES; GENETIC SCREENING; HUMANS; PANCREATIC ELASTASE; PANCREATIC FUNCTION TESTS; PANCREATITIS, CHRONIC;

EID: 69649109369     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32832e1600     Document Type: Review

References (35)

1. Bernard C, Henderson JT. Memoir on the pancreas and on the role of pancreatic juice in digestive processes, particularly on the digestion of neutral fat. Monogr Physiol Soc 1985; 42:1-131.
2. •] that outlines the availability, timing and application of diagnostic tests for chronic pancreatitis and EPI.
3. Parsi MA, Conwell DL, Zuccaro G, et al. Findings on endoscopic retrograde cholangiopancreatography and pancreatic function test in suspected chronic pancreatitis and negative cross-sectional imaging. Clin Gastroenterol Hepatol 2008; 6:1432-1436. This study reports that peak lipase concentration during CCK-stimulated ePFT is 93% sensitive for diagnosing chronic pancreatitis in patients whose pancreas appears normal by cross-sectional imaging. The specificity, however, was only 37% in 11 patients deemed not to have chronic pancreatitis after a median follow-up of 7 years. Because of established high specificity of direct, quantitative PFTs, it is likely that the low negative predictive value is due to correctable technical limitations of the study or failure to exclude confounding diseases.
4. Hahn JU, Kerner W, Maisonneuve P, et al. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas 2008; 36:274-278. In 33 patients with type I diabetes mellitus, the research team compared the results of direct stimulatory secretin-caerulein PFT and the fecal elastase tests and found that a low fecal elastase has an unacceptably low specificity and positive predictive value for EPI.
5. Pollard HM, Miller L, Brewer WA. The external secretion of the pancreas and diabetes mellitus. Am J Dig Dis 1943; 10:20-23.
6. Chey WY, Shay H, Shuman CR. External pancreatic secretion in diabetes mellitus. Ann Intern Med 1963; 59:812-821.
7. Frier BM, Saunders JH, Wormsley KG, Bouchier IA. Exocrine pancreatic function in juvenile-onset diabetes mellitus. Gut 1976; 17:685-691.
8. Lankisch PG, Manthey G, Otto J, et al. Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion 1982; 25:211-216. (Pubitemid 13187258)
9. Creutzfeldt W, Gleichmann D, Otto J, et al. Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion 2005; 72:71-75. (Pubitemid 41507265)
10. Bilgin M, Balci NC, Momtahen AJ, et al. MRI and MRCP findings of the pancreas in patients with diabetes mellitus: compared analysis with pancreatic exocrine function determined by fecal elastase 1. J Clin Gastroenterol 2009; 43:165-170.
11. •], the lack of a gold standard for diagnosing chronic pancreatitis and the unblinded and retrospective data analysis.
12. •] and the lack of a gold standard for diagnosing chronic pancreatitis and the unblinded and retrospective data analysis. Hence, it remains uncertain whether MRI/MRCP correlates with results of the secretin-stimulated PFT.
13. •].
14. ••]), the authors emphasize that '. . . it is imperative to thoroughly rule out other possible causes of pancreatic disease'.
15. •], there is large overlap of values among groups of patients (AIP vs. chronic pancreatitis vs. pancreatic cancer), limiting the usefulness of this test.
16. •], there is large overlap of values among groups of patients (AIP vs. chronic pancreatitis vs. pancreatic cancer), limiting the usefulness of this test.
17. Kamisawa T, Satake K. Therapeutic strategy for autoimmune pancreatitis. Adv Med Sci 2008; 53:145-148. A review article about the clinical characteristics of AIP, differentiation from other mass lesions and a suggested algorithm for treating with corticosteroids.
18. Park do H, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008; 134:440-446. From clinical follow-up of a median 4 years in 40 patients with AIP, Park et al. report that substitution of aspartic acid to nonaspartic acid at DQ-1 57 predicts relapse of AIP and that homozygotes for nonaspartic acid had an earlier mean relapse than heterozygotes (6.7 vs. 33 months) after cessation of steroids.
19. ••]) that points out the difficulty of associating HLA class I and II alleles with a specific disease, particularly the limitations, when statistical adjustments are required because of multiple comparisons, and urges further confirmation of the results by others.
20. Strum WJ. Abstinence in alcoholic chronic pancreatitis. Effect on pain and outcome. J Clin Gastroenterol 1995; 20:37-41.
21. Trapnell JE. Chronic relapsing pancreatitis: a review of 64 cases. Br J Surg 1979; 66:471-475. (Pubitemid 10233600)
22. Lankisch PG, Lohr-Happe A, Otto J, Creutzfeld W. Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion 1993; 54:148-155.
23. Ammann RW, Muellhaupt B, Meyenberger C, Heitz PU. Alcoholic nonprogressive chronic pancreatitis: prospective long-term study of a large cohort with alcoholic acute pancreatitis (1976-1992). Pancreas 1994; 9:365-373.
24. Bornman PC, Marks IN, Girdwood AH, et al. Is pancreatic duct obstruction or stricture a major cause of pain in calcific pancreatitis? Br J Surg 1980; 67:425-428.
25. Strate T, Taherpour Z, Bloechle C, et al. Long-term follow-up of a randomized trial comparing the Beger and Frey procedures for patients suffering from chronic pancreatitis. Ann Surg 2005; 241:591-598. (Pubitemid 40397306)
26. Ammann RW, Muellhaupt B. Progression of alcoholic acute to chronic pancreatitis. Gut 1994; 35:552-556. (Pubitemid 24131256)
27. Nordback I, Pelli H, Lappalainen-Lehto R, et al. The recurrence of acute alcohol-associated pancreatitis can be reduced: a randomized controlled trial. Gastroenterology 2008; 136:848-855. A prospective, randomized controlled trial that reports that repeated clinical visits at 6-month intervals to counsel patients to abstain from alcohol appear to reduce the development of RAP during a 2-year period.
28. Szuster-Ciesielska A, Daniluk J, Kandefer-Szerszen M. Oxidative stress in blood of patients with alcohol-related pancreatitis. Pancreas 2001; 22:261-266. (Pubitemid 32242491)
29. Verlaan M, Roelofs HM, van-Schaik A, et al. Assessment of oxidative stress in chronic pancreatitis patients. World J Gastroenterol 2006; 12:5705-5710. (Pubitemid 44594048)
30. Braganza JM, Schofield D, Snehalatha C, Mohan V. Micronutrient antioxidant status in tropical compared with temperate-zone chronic pancreatitis. Scand J Gastroenterol 1993; 28:1098-1104. (Pubitemid 23350730)
31. Uden S, Schofield D, Miller PF, et al. Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial. Aliment Pharmacol Ther 1992; 6:229-240.
32. Kirk GR, White JS, McKie L, et al. Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. J Gastrointest Surg 2006; 10:499-503.
33. Bhardwaj P, Garg PK, Maulik SK, et al. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009; 136:149-159e142. A double-blind randomized controlled trial shows that a five-component antioxidant cocktail may reduce the frequency of pain in chronic pancreatitis by 1.5 days per month compared with placebo.
34. DeBenedet AT, DiMagno MJ. Commentary on: a randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009; 136:149-159; www.f1000medicine.com.
35. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297:842-857. (Pubitemid 46333949)